Daniel Faga
Board Member
Anaptysbio, Inc (ANAB)Equibles does not estimate personal net worth.
Get an email with a short summary when Anaptysbio, Inc publishes a filing, an earnings call transcript or a press release.
Get ANAB alertsAbout Daniel Faga
Daniel Faga is recorded as Board Member and CEO at Anaptysbio, Inc (ANAB). The newest filing on record that lists Daniel Faga as Board Member and CEO at Anaptysbio, Inc (ANAB) is dated June 29, 2026. Anaptysbio, Inc reported in an 8-K filed March 27, 2026 that Daniel Faga was appointed Board of Directors. Anaptysbio, Inc reported in an 8-K filed March 27, 2026 that Daniel Faga was appointed president and CEO of First Tracks Bio. The proxy statement of Anaptysbio, Inc reports total compensation of $6,133,943 for Daniel Faga in fiscal 2025, including a base salary of $706,011. Disclosed compensation is on record for 4 fiscal years. Anaptysbio, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Anaptysbio, Inc includes John Orwin (Chairman and Board Member), Ajim Tamboli (CFO), Christopher M. Murphy (CFO) and 7 others.
“• | Board of Directors will include certain current members of Anaptys’ Board: Daniel Faga; Dennis Fenton,Ph.D.; John Orwin (Chairman); John Schmid; Magda Marquet, Ph.D.; Rita Jain, M.D.; and Tony Ware, M.D. |”
““The spin-off of First Tracks into an independent, public company is a strategic step that unlocks the value of our potentially best-in-class development pipeline focused on autoimmune diseases. With an initial two-year cash runway, we are positioned to carve a new trail toward a future where autoimmune diseases no longer define a patient’s life,” said Daniel Faga, who will serve as president and CEO of First Tracks Bio, and as Anaptys’ CEO.”
Affiliation history
-
Current
Start not stated–present
Last confirmed June 29, 2026
-
Current
Start not stated–present
Last confirmed June 29, 2026
Company network
Leadership on record at Anaptysbio, Inc
- John Orwin Chairman, Board Member
- Ajim Tamboli CFO
- Christopher M. Murphy CFO
- Dominic G. Piscitelli CFO
- Eric Loumeau COO
- Dennis Fenton Board Member
- Hollings Renton Board Member
- John P. Schmid Board Member
- John Schmid Board Member
- Magda Marquet Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Anaptysbio, Inc (ANAB) | President and Chief Executive Officer and Director | $706,011 | $6,133,943 |
| 2024 | Anaptysbio, Inc (ANAB) | President and Chief Executive Officer and Director | $685,448 | $13,630,292 |
| 2023 | Anaptysbio, Inc (ANAB) | President and Chief Executive Officer and Director | $640,605 | $7,461,920 |
| 2022 | Anaptysbio, Inc (ANAB) | President and Chief Executive Officer and Director | $483,578 | $24,440,350 |